IDO1 and thyroid cancer: The expression of NKp46 and NKG2D receptors was decreased by kynurenine, consistent with NK receptor expression decrease observed after co-culture with thyroid cancer cells, and they were both restored by treatment with the IDO inhibitor (Figure 2).